Pharsight

Clarus patents expiration

1. Jatenzo patents expiration

JATENZO's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US11179402 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Apr, 2026

(2 years from now)

US10617696 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(6 years from now)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11331325 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Jan, 2027

(3 years from now)

US8241664 CLARUS Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Mar, 2029

(5 years from now)

US8778916 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(6 years from now)

US11426416 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(6 years from now)

US10543219 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(6 years from now)

US11179403 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Apr, 2030

(6 years from now)

US8492369 CLARUS Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same
Dec, 2030

(7 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Product (NP) Mar 27, 2022

Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient

Market Authorisation Date: 27 March, 2019

Treatment: Method of treating testosterone deficiency; A method of treating testosterone deficiency in men

Dosage: CAPSULE;ORAL

More Information on Dosage

JATENZO family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic